Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD, FASN
PeerManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
How to Integrate AKI Risk Assessments into Clinical Workflows
How to Take a Proactive Approach to AKI Risk Assessment and Management
Assessing AKI Risk: Best Practices for Biomarker Testing
Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
The Pathophysiology of Anemia of CKD
Steven Fishbane, MD
PeerThe Current Standard of Care and Unmet Need in Anemia of CKD
Sophia Ambruso, DO
PeerPrevalence and Burden of Anemia of CKD
Girish Nadkarni, MD, MPH
PeerMechanism of Disease: Immunoglobulin A Nephropathy
A Review of Kidney Biopsy in Complement-Mediated Kidney Diseases
Mark Haas, MD
PeerThe Four-Hit Model of IgA Nephropathy Pathogenesis
Jai Radhakrishnan, MD
Peer